NANETS Monthly Virtual Programming Series - NANET/SNMMI Part II

Date
10.20.2021 6:00 pm - 7:00 pm

Description

Practical Considerations for Administering High-Dose Therapies

High-dose radioligand therapy requires a unique set of institutional procedures and protocols, but with certain safety measures in place, your health care institution can provide this treatment regimen that is shown to improve quality of life and perhaps survival for patients with metastatic and unresectable pheochromocytoma/paraganglioma. This session will examine the practical considerations needed to introduce mIBG therapy.

Speakers
Oncologist Perspective: Bhavana Konda, MD, MPH, Associate Professor-Clinical, Ohio State University

Radiation Safety Officer Perspective: Maxwell Amurao, PhD, MBA, Director of the Office of Radiation Safety, Washington University in St. Louis

Nuclear Medicine Physician Perspective: David Taieb, MD, PhD, Professor, Aix-Marseille Université

Moderated by Debbie Cohen, MD, Director, Pheochromocytoma/Paraganglioma Neuroendocrine Tumor Program, University of Pennsylvania

This event is free and open to members and non-members.

Register Here